Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eptinezumab, ATC N02CD05

This is not an open procedure, but a so-called open-house model! The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded in the open-house model do not fall under public procurement law due to the lack of a selection decision. The use of this form does not involve any submission to public procurement regulations. AOK Bayern intends to enter into non-exclusive discount agreements with all interested pharmaceutical companies for the active substance Eptinezumab, ATC N02CD05, in accordance with § 130c para. 1 SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below the opportunity to conclude identical and non-individually negotiable discount agreements. The earliest possible start date for the contract is 01.05.2026, and all contracts end on 30.04.2028. A contract can be concluded at any time during this period, but at the latest by 03.03.2028. The contracts can be terminated with one month's notice at the end of the month. If a nationwide or state-specific discount contract for medicines with the subject matter of the contract comes into force, the open-house agreements will automatically cease to apply for the corresponding term. A contract will be concluded with all interested pharmaceutical companies that prove their eligibility by completing and signing a self-declaration of reliability. The pharmaceutical company must submit the completed and signed (the authorization of the signatory/s must be evident from the commercial register extract, otherwise a power of attorney must be submitted) contract together with the completed and signed attachment "Specification of the contractual medicines" and the completed and signed self-declaration of reliability. The documents can be submitted EITHER IN WRITING by hand-signed OR ELECTRONICALLY with a qualified electronic signature. Hand-signed documents in WRITING must be sent in duplicate in original form to the following address: AOK Bayern - Die Gesundheitskasse Vergabestelle SGB V ZE25 open-house Rabattverträge Carl-Wery-Str. 28 81739 München ELECTRONIC documents with a qualified electronic signature are to be submitted via the communication area in the tendering portal www.dtvp.de. If complete and correct documents are received by the 3rd of each month, the contract will commence on the first day of the following month, otherwise on the first day of the month after next. In the case of hand-signed documents in WRITING, the complete, filled-in and signed documents must be sent in advance as a scan to the e-mail address [email protected] or via the communication area in the tendering portal www.dtvp.de in a timely manner, provided that the complete and correct original documents in paper form are received by the AOK Bayern, Vergabestelle, by the 10th of the month. Please note the completion instructions, which are available under www.dtvp.de with the tender documents. Interested pharmaceutical companies can request the release of the tender documents in the project room for the open-house procedure on the portal www.dtvp.de. A link to the portal is included in this notice. Only pharmaceutical companies are considered as potential contractual partners. The documents of the open-house procedure will only be released to pharmaceutical companies as potential contractual partners and must be treated as strictly confidential. By requesting the release, the companies confirm the confidential treatment of the documents.